GlassScriptPhysician profile
Cody E Campbell
NPI 1801359690
$568.42
in general payments reported to CMS, 2019-2025
9 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2023: $156 · 2024: $158 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $157.09 | 2023-2025 | Slynd |
| Abbvie INC. | $116.55 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $80.72 | 2023-2024 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Boston Scientific Corporation | $76.15 | 2025 | Axonics |
| Mayne Pharma Commercial LLC | $50.65 | 2024-2025 | |
| Axonics, INC. | $41.82 | 2023 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $16.87 | 2025 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $14.36 | 2025 | |
| Astellas Pharma US INC | $14.21 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.